Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine?


Por: R. ENSENAT-WASER, A. PELLICER and C. SIMON

Publicada: 1 abr 2009
Resumen:
Human embryonic stem cells have the greatest potential for regenerative and reproductive medicine; unfortunately, their full application is limited by ethical and technical problems. In order to overcome these problems and get patient specific pluripotent cells from somatic cells, the field of reprogramming has moved to the generation of induced pluripotent stem cells by overexpression of four transcription factors after viral infection of the patient's somatic cells. In the present paper we review the limitations and milestones of this technique in both regenerative and reproductive medicine. (Fertil Steril (R) 2009;91.:971-4. (C) 2009 by American Society for Reproductive Medicine.)

Filiaciones:
R. ENSENAT-WASER:
 Prince Felipe Res Ctr CIFP, Spanish Stem Cell Bank, Valencia 46013, Spain

A. PELLICER:
 Univ Valencia, FIVI, Valencia, Spain

:
 Prince Felipe Res Ctr CIFP, Spanish Stem Cell Bank, Valencia 46013, Spain

 Univ Valencia, FIVI, Valencia, Spain
ISSN: 00150282





FERTILITY AND STERILITY
Editorial
ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, NY 10169, Estados Unidos America
Tipo de documento: Editorial Material
Volumen: 91 Número: 4
Páginas: 971-974
WOS Id: 000265132300002
ID de PubMed: 19200985

MÉTRICAS